Aclarion Announces First Commercial Agreement In Michigan; Sheridan Community Hospital Is The First Healthcare Institution In Michigan With Nociscan
Portfolio Pulse from Benzinga Newsdesk
Aclarion, Inc. (NASDAQ: ACON) has announced a commercial agreement with Sheridan Community Hospital in Michigan, making it the first healthcare institution in the state to adopt Nociscan. This agreement will expand access to Nociscan for John Keller, MD, a leading neurosurgeon and Aclarion Medical Advisor, and his patients in central Michigan.
August 14, 2024 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aclarion, Inc. has entered into a commercial agreement with Sheridan Community Hospital in Michigan, making it the first in the state to use Nociscan. This partnership will enhance the company's market presence and potentially increase revenue.
The commercial agreement with Sheridan Community Hospital marks a significant expansion for Aclarion's Nociscan technology in Michigan. This partnership with a leading neurosurgeon could lead to increased adoption and revenue, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100